This article is for informational purposes only and does not constitute medical advice. Never stop or change olmesartan without your doctor's guidance. Always consult your prescribing physician before changing your blood pressure medication.
Olmesartan does not have classic withdrawal symptoms. The ARB class has no documented rebound hypertension, no sympathetic overactivity, and no FDA-warned discontinuation syndrome. Your blood pressure drifts back to its untreated baseline over 5 to 7 days, not a sudden 48-hour spike. That is meaningfully gentler than beta-blockers or clonidine, but does not mean you should stop on your own.
Why ARBs Are Different When You Stop
Antihypertensive drugs vary widely in how they behave when discontinued. Olmesartan, like other angiotensin II receptor blockers (ARBs), is one of the gentler classes. A 2018 review of ARBs in hypertension management (Burnier, in Drugs in Context) notes that ARBs have low discontinuation rates compared to other antihypertensive drug classes and lower withdrawal-for-adverse-events rates than ACE inhibitors.
An earlier review in Advances in Therapy states it directly: olmesartan can be stopped abruptly without tapering, with no evidence of rebound hypertension after discontinuation.
The 2025 AHA/ACC hypertension guideline singles out clonidine and beta-blockers as drugs that explicitly require tapering to avoid rebound. ARBs are not in that high-risk category.
The 5 to 7-Day BP Drift Timeline
Olmesartan has a terminal elimination half-life of about 13 hours, per the FDA prescribing information. That is short enough that the drug clears within a few days, but long enough that BP rebound is gradual rather than abrupt.
Here is a typical pattern after stopping:
| Time | What is happening | What you might feel |
|---|---|---|
| Day 1 to 2 | Drug levels falling but still active | Usually nothing |
| Day 3 to 5 | Drug levels low, BP starting to drift up | Possible mild dizziness or headache as BP changes |
| Day 5 to 7 | Steady state at untreated baseline | BP at pre-treatment numbers; if your hypertension was severe, that level can be dangerous |
This is gentler than the 48-hour rise window with lisinopril and similar to amlodipine's 7-to-10-day drift. The "no rebound" finding does NOT mean BP stays controlled. It means BP does not OVERSHOOT your pre-treatment baseline. It will return to wherever your hypertension was before treatment, which is exactly the level your doctor was trying to fix.
The Sprue-Like Enteropathy Exception
Most articles about stopping olmesartan miss this entirely. Olmesartan is the only ARB the FDA has issued a warning for sprue-like enteropathy, a serious GI condition that causes chronic diarrhea and substantial weight loss. The 2013 FDA Drug Safety Communication noted that symptoms typically resolve after stopping olmesartan and may take weeks to months to improve.
In other words, sometimes your doctor will recommend stopping olmesartan because of this side effect. The "withdrawal" you experience in that case is partly the BP drift described above and partly the GI recovery, which is what you actually wanted.
If you have had unexplained chronic diarrhea or weight loss while on olmesartan, talk to your doctor. Switching to a different ARB (like losartan) or a different drug class may be the right move.
Why Lisinopril Withdrawal Searches Are Different
If you have been Googling "olmesartan withdrawal symptoms" hoping to find a list like the SSRI withdrawal lists, you have probably noticed the lists are short or absent. That is because the symptoms most people are searching for (anxiety, racing heart, brain zaps, sweating) belong to drugs in different classes.
The 2005 review of antihypertensive withdrawal in International Journal of Clinical Practice (Karachalios et al.) placed those classic withdrawal symptoms with clonidine, beta-blockers, methyldopa, and guanabenz. ARBs are not on that list.
So if you stop olmesartan and feel "weird," the likely culprits are: BP drifting up (causing headache or fatigue), the underlying condition coming back, or an unrelated cause. Talk to your doctor.
Example 4 to 8-Week Taper Calendar
Even though olmesartan does not require tapering for withdrawal-syndrome reasons, doctors usually still recommend a structured taper so they can monitor BP drift and decide whether you need a replacement. Below is an example schedule modeled on the Reeve et al. 2024 deprescribing protocol. This is illustrative only. Your doctor must approve and adjust based on your dose, BP readings, and reason for stopping.
| Week | Phase | Example dose action | What to monitor |
|---|---|---|---|
| Weeks 1 to 4 | Step 1 reduction | Reduce ~50% (e.g., 40 mg to 20 mg, or 20 mg to 10 mg) | Daily AM and PM BP. Note any GI improvement if stopping for sprue-like enteropathy. |
| Weeks 5 to 8 | Off medication | Stop entirely | Daily BP for 14 days, then alternate days. Restart or switch agents if BP exceeds 140/90 across 3 readings in 7 days. |
| Week 9 and beyond | Sustained monitoring | None | Weekly BP, plus a clinic visit at month 3 and month 6. |
If you are stopping because of side effects (sprue-like enteropathy, dizziness, kidney function changes), your doctor may switch you to losartan or another ARB rather than discontinue BP treatment entirely. Compare timing in best time to take losartan if that is the path.
If you are stopping because your BP is well controlled and you may not need medication anymore, the Reeve et al. 2024 review reports that about 1 in 3 patients who attempt deprescribing in clinical trials end up needing to restart. Plan for that possibility.
Warning Signs You Need to Restart or Switch
| Sign | What it means | Action |
|---|---|---|
| BP over 140/90 on 3 readings in a week | BP drift to disease baseline | Call your doctor within 24 to 48 hours |
| Headache, vision changes, confusion | Possible hypertensive crisis | Call your doctor or 911 immediately |
| Chest pain, shortness of breath | Possible cardiac event | Call 911 |
| GI symptoms persist beyond 6 weeks off olmesartan | Sprue-like enteropathy may need further evaluation | GI specialist referral |
For broader context, see medications you should never skip and our hub article on what happens if you stop taking blood pressure medication.
How Pillo Helps
Even with a gentle pharmacology, an olmesartan taper involves multiple dose changes and daily BP logging. Pillo sets persistent alarms that switch with your dose schedule and lets you log BP readings alongside doses. The combined record gives your doctor a clean picture of how your body responded to each step.
Download Pillo on Google Play.
Frequently Asked Questions
Does olmesartan cause withdrawal symptoms?
No. Olmesartan and other ARBs do not cause classic withdrawal symptoms. The Karachalios 2005 review places that risk with clonidine, beta-blockers, methyldopa, and guanabenz, not ARBs. What you may notice instead is your blood pressure rising back to its pre-treatment levels over 5 to 7 days.
Can I stop olmesartan cold turkey?
Pharmacologically, yes. The ARB literature reports no rebound hypertension after olmesartan discontinuation. That said, you still should not stop on your own. Your BP will return to its untreated level, which is what your doctor was treating in the first place. Always coordinate stopping with your prescriber.
How long does olmesartan stay in your system?
Olmesartan has a terminal elimination half-life of about 13 hours per the FDA label. It typically takes 2 to 3 days to clear, with BP returning to baseline by day 5 to 7.
What is the sprue-like enteropathy with olmesartan?
It is a rare but serious GI side effect first warned by the FDA in 2013, characterized by chronic diarrhea, weight loss, and intestinal villous atrophy. Symptoms usually resolve after stopping olmesartan and may take weeks to months to improve. If you have had unexplained chronic diarrhea while on olmesartan, talk to your doctor about switching agents.
Should I taper olmesartan or just stop?
Tapering is still recommended even though pharmacologic rebound is not a concern. The reason is BP monitoring and giving your doctor the chance to substitute another agent if your BP returns to dangerous levels. The Reeve et al. 2024 deprescribing review reports about 1 in 3 patients need to restart, so a structured taper with home BP logs makes that decision easier.
This article provides general information about olmesartan and is not a substitute for professional medical advice. Never stop or change olmesartan without your doctor's guidance. Consult your prescribing physician about your specific medications and health conditions.
Reviewed under our Medical Review Policy.
